These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21707798)

  • 1. Identifying transmission routes for hepatitis B and C in recently infected blood donors in England--challenges to obtaining post-test information.
    Reynolds CA; Davison KL; Gilbart VL; Brailsford SR; Brant LJ
    Transfus Med; 2011 Oct; 21(5):351-3. PubMed ID: 21707798
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
    Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
    Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-transfusion viral hepatitis].
    Katayama T
    Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
    [No Abstract]   [Full Text] [Related]  

  • 6. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.
    Can Dis Wkly Rep; 1991 Nov; 17(46):251-7; discussion 257-8. PubMed ID: 1843654
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-transfusion hepatitis: analysis of risk factors.
    Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
    Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatitis following transfusion].
    Fürst G; Kostuch B; Peichl-Hoffmann G; Kellner S
    Beitr Infusionsther; 1988; 21():187-91. PubMed ID: 2462974
    [No Abstract]   [Full Text] [Related]  

  • 12. [The problem of post-transfusion hepatitis].
    Sugg M
    Beitr Infusionther Klin Ernahr; 1986; 15():30-8. PubMed ID: 3019299
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-transfusion hepatitis].
    Frey-Wettstein M
    Schweiz Med Wochenschr Suppl; 1980; (10):1-40. PubMed ID: 6769160
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience.
    Sultan F; Mehmood T; Mahmood MT
    Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
    Dwyre DM; Fernando LP; Holland PV
    Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can donors with prior hepatitis be safely used for heart transplantation?
    Mawhorter SD; Avery RK
    J Heart Lung Transplant; 2006 Jul; 25(7):805-13. PubMed ID: 16818123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response rate of Malaysian blood donors with reactive screening test to transfusion medicine unit calls.
    Roshan TM; Rosline H; Ahmed SA; Rapiaah M; Khattak MN
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1315-21. PubMed ID: 20578467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
    Boutayeb H; Aamoum A; Benchemsi N
    East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.